Navigation Links
Laborie Medical Technologies Receives FDA Pre-Market Clearance for TETRA(TM)- NIRS Accessory for the US Market
Date:3/10/2008

ladder modeling tools, EMR solutions, consumables, as well as accredited education.

The network of installed users has afforded LABORIE the opportunity to feed this network with new and exciting technology on a continuous basis. Recently, LABORIE introduced the world's most compact, high resolution USB ultrasound system (NuWav(TM)), and it intends on providing the TETRA(TM) technology in the same manner. LABORIE has offices in Canada, USA, Belgium, China, UK and now Paris, France and San Paulo, Brazil. It has direct sales and distribution networks in 52 countries across North America, Europe, Asia and Oceania.


'/>"/>
SOURCE Laborie Medical Technologies
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. MSU engineering team designs innovative medical device
2. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
3. Providence St. Joseph Medical Center, Caregivers Reach Agreement on a Union Contract
4. Owner and Operator of Florida Durable Medical Equipment Company Convicted of Medicare Fraud
5. Father and Daughter From Tanzania Receive Their First Medical Examination in Newport Beach
6. Doctors and medical ethicist discuss whether doctors should participate in capital punishment
7. Preparation for Natural Disasters Critical for People With Diabetes, Chronic Medical Conditions
8. Doctors and Medical Ethicist Discuss Whether Doctors Should Participate in Capital Punishment
9. Symmetry Medical Completes Acquisition Of Specialty Surgical Instruments
10. Milestone Scientific Announces Successful Completion of its Collaboration Agreement With Carticept Medical
11. FDA Seeks to Regulate Complementary and Alternative Medicine; Products Such as Vegetable Juice Could Be Restricted for Medical Use
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...exas Health Science Center at Houston will launch ...s (TEXAS), to promote geriatrics training for phys... the Donald W. Reynolds Foundation and $1.25 milli...ch geriatric medicine principles to everyone from ...icians. With the reach of Lyndon B. Johnson Genera...
(Date:11/21/2008)...ll/ -- The Providence Service,Corporation (Nasdaq...he Company,s,Chief Operating Officer, has been ap... Norris, appointment fills the vacancy left by the... returns the board to six members. Mr.,Norris wi... Mr. Norris, age 41, has been with Providence si...
(Date:11/21/2008)...nst Lennox-Gastaut syndrome , , FRIDAY, ...el (rufinamide) has been approved as a supplementa...Lennox-Gastaut syndrome, the U.S. Food and Drug Ad...as based on results of a four-month clinical trial...patients who took a placebo, those who took the dr...
(Date:11/21/2008)...ewswire/ -- New research at West Virginia Univers...bacco product aimed at young adults is catching on... Camel Snus - touted as a socially acceptable way ...levels of nicotine. , , "Camel Snus contain...aid Bruce Adkins of the state Division of Tobacco ...
Breaking Medicine News(10 mins):Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 2Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 3Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 4Health News:Craig A. Norris Appointed to Providence Service Corporation Board of Directors 2Health News:Craig A. Norris Appointed to Providence Service Corporation Board of Directors 3Health News:FDA Approves New Drug for Severe Epilepsy 2Health News:Experts Say New Tobacco Product Targets Young Adults 2Health News:Experts Say New Tobacco Product Targets Young Adults 3
...e ‘Mini’ Way to Stop Atrial Fibrillation in its Tr...ds of Americans with intermittent atrial fibrillat... of the Cox-Maze procedure //that involves scarrin...es sent by the brain to travel correctly. Richard ...
...bert Watson, a graduate student in the Section of ...f Medicine has found the uncommon path taken by Ca...s cells. Records show that, "campylobacteriosis,"...rhea worldwide, strikes 2.4 million Americans a ye...
...ala Lumpur: Five Malaysian states have registered ...first week of the year, with authorities fearing t...ead due to the rainy season, reports said Wednesda...an registered the highest jump, from 18 cases in t...
...new study finds that obesity increases the risk of...ot increase the overall risk a man will be diagnos... CANCER, a peer-reviewed journal of the American C... higher body mass index (BMI) and weight gain in a...
Other Medicine News:Health News:The Uncommon Pathway of Campylobacter Jejuni 2Health News:Mosquito-borne Dengue Disease on the Rise in Five Malaysian States 2Health News:Excess Weight and Adult Weight Gain Increase Risk of Prostate Cancer Death 2
(Date:11/20/2008)...NE RESULTS OF FIRST PHASE III TRIAL SHOW SIGNIFICA...EMENT IN DAILY FUNCTION, IN, ...if., and BRUSSELS, Belgium, Nov. 20 /PRNewswire-Fi... JAZZ ) and UCB (Euronext Brussels: UCB),announce... the first of two,Phase III pivotal clinical tria...
(Date:11/20/2008)... 20 Duska Therapeutics,... that it has submitted its,pivotal Phase 3 ATPace...l,Protocol Assessment (SPA) procedure with the U....ubject to securing an agreement with the FDA, Dusk...le-blind, placebo-controlled and randomized Phase ...
(Date:11/20/2008)...vember 20 The Scandinavian-based d...nced results of studies on its,lead antimicrobial...on, DC,the studies showed that the novel lytic p...fect, significantly better towards killing Staphyl...rketed gold standard drugs. In,addition to this i...
(Date:11/19/2008)...port basic findings on critical enzyme,s regulatio...t an array of disorders , , MEMPHIS, Tenn.,... St. Jude Children,s Research Hospital have gained... enzyme workhorses called calpains. , , As...tion in many cellular processes, including the mov...
Breaking Medicine Technology:Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 2Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 3Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 4Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 5Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 6Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 2Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 3Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 4Lytix Presents LTX-109 Anti-Microbial Data at ICAAC 2New Insight Into the Controls on a Go-To Enzyme 2New Insight Into the Controls on a Go-To Enzyme 3National Federation of the Blind to Award 24100 000 7690 1National Federation of the Blind to Award 24100 000 7690 2Inspirational Medical Teachers Honored with Mentor Awards from the American Society of Hematology 7685 1Inspirational Medical Teachers Honored with Mentor Awards from the American Society of Hematology 7685 2ASH Holds a Special Symposium to Interest High School Students in Biomedical Research 2082 1ASH Holds a Special Symposium to Interest High School Students in Biomedical Research 2082 2New choices for patients 3A Transfusion free medicine for Jehovahs Witnesses and transfusion wary 7681 1New choices for patients 3A Transfusion free medicine for Jehovahs Witnesses and transfusion wary 7681 2
...IRE)--Mar 27, 2007 - Interleukin,Genetics, Inc. (A...lifornia San Diego today reported at the American ...ions between coronary artery,disease (CAD) and bot...ppear to be dependent on pro-inflammatory variants...tion titled "The Influence of Oxidized,Phospholipi...
...l for Vaccine Delivery System, NYON, Switzerland, ...Corporation announced today that the Company,s HIV...human primate model.,Mucosal IgA antibodies are co...infection by HIV. The data were presented by,Sylva...er in an,oral presentation, "Without Mucosal Adjuv...
Other Medicine Technology:ACC Presentation Indicates Interleukin-1 Gene Variants Determine,Increased Risk for Coronary Artery Disease from Oxidized,Phospholipids 2ACC Presentation Indicates Interleukin-1 Gene Variants Determine,Increased Risk for Coronary Artery Disease from Oxidized,Phospholipids 3Mymetics' HIV Vaccine Achieves Research Breakthrough, Eliciting,Protective Antibody Response in Mucosal Tissues of Non-Human,Primate Model 2Mymetics' HIV Vaccine Achieves Research Breakthrough, Eliciting,Protective Antibody Response in Mucosal Tissues of Non-Human,Primate Model 3Mymetics' HIV Vaccine Achieves Research Breakthrough, Eliciting,Protective Antibody Response in Mucosal Tissues of Non-Human,Primate Model 4
Kaye Skin Hook, Single Prong
Designated most popular model or size.
Large deep curve.
Needle tip electrode, davol advantage electrosurgical attachments, 33cm (with extendible outer sheath), non-sterile. These products are supplied non-sterile and must be sterilized before use. Reusabl
Medicine Products: